Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

• Published in: Antimicrobial Agents and Chemotherapy Vol. 51; no. 9; pp. 3063 - 3066
• Main Authors: Martin, David E., Blum, Robert, Wilton, John, Doto, Judy, Galbraith, Hal, Burgess, Gina L., Smith, Philip C., Ballow, Charles
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.09.2007
• Subjects: Adolescent; Adult; Anti-HIV Agents; Anti-HIV Agents - administration & dosage; Anti-HIV Agents - adverse effects; Anti-HIV Agents - pharmacokinetics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Area Under Curve; Biological and medical sciences; Dose-Response Relationship, Drug; Double-Blind Method; Human immunodeficiency virus; Human viral diseases; Humans; Immunodeficiencies; Immunodeficiencies. Immunoglobulinopathies; Immunopathology; Infectious diseases; Male; Medical sciences; Middle Aged; Pharmacology; Pharmacology. Drug treatments; Succinates; Succinates - administration & dosage; Succinates - adverse effects; Succinates - pharmacokinetics; Triterpenes; Triterpenes - administration & dosage; Triterpenes - adverse effects; Triterpenes - pharmacokinetics; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Human; Immunopathology; Antiretroviral agent; Healthy subject; Toxicity; Retroviridae; AIDS; Bevirimat; Immune deficiency; Lentivirus; Infection; Virus; Viral disease; Antiviral; Inhibitor; Human immunodeficiency virus; Pharmacokinetics

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...